IL142220A0 - Method of treating viral hemorrhagic fever - Google Patents
Method of treating viral hemorrhagic feverInfo
- Publication number
- IL142220A0 IL142220A0 IL14222099A IL14222099A IL142220A0 IL 142220 A0 IL142220 A0 IL 142220A0 IL 14222099 A IL14222099 A IL 14222099A IL 14222099 A IL14222099 A IL 14222099A IL 142220 A0 IL142220 A0 IL 142220A0
- Authority
- IL
- Israel
- Prior art keywords
- hemorrhagic fever
- viral hemorrhagic
- treating viral
- provides
- toxicity
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4866—Protein C (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10915398P | 1998-11-20 | 1998-11-20 | |
PCT/US1999/027074 WO2000030677A1 (en) | 1998-11-20 | 1999-11-15 | Method of treating viral hemorrhagic fever |
Publications (1)
Publication Number | Publication Date |
---|---|
IL142220A0 true IL142220A0 (en) | 2002-03-10 |
Family
ID=22326085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14222099A IL142220A0 (en) | 1998-11-20 | 1999-11-15 | Method of treating viral hemorrhagic fever |
Country Status (12)
Country | Link |
---|---|
US (2) | US6270764B1 (ja) |
EP (1) | EP1131091B1 (ja) |
JP (1) | JP2002530353A (ja) |
CN (1) | CN1326356A (ja) |
AT (1) | ATE235915T1 (ja) |
AU (1) | AU2149800A (ja) |
BR (1) | BR9915460A (ja) |
CA (1) | CA2351470A1 (ja) |
DE (1) | DE69906568T2 (ja) |
ES (1) | ES2195655T3 (ja) |
IL (1) | IL142220A0 (ja) |
WO (1) | WO2000030677A1 (ja) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69906568T2 (de) * | 1998-11-20 | 2004-02-12 | Eli Lilly And Co., Indianapolis | Behandlung von hämorrhagischem virusfieber mit protein c |
WO2002024215A2 (en) * | 2000-09-18 | 2002-03-28 | Eli Lilly And Company | Method for using activated protein c for the treatment of coagulation-associated disorders |
KR20040040489A (ko) | 2001-10-15 | 2004-05-12 | 카이론 코포레이션 | 조직 인자 경로 억제제(tfpi)의 저용량 투여에 의한패혈증의 치료 |
US7132398B2 (en) | 2003-05-06 | 2006-11-07 | Dendreon Corporation | Method of treatment of hemorrhagic disease using a factor VIIa/tissue factor inhibitor |
SG150552A1 (en) * | 2004-03-17 | 2009-03-30 | Chiron Corp | Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (tfpi) |
WO2007092607A2 (en) * | 2006-02-09 | 2007-08-16 | Genetech, Inc. | Treatment of hemorrhagic viral infections using a tissue factor inhibitor |
AU2016431615A1 (en) * | 2016-12-08 | 2019-06-20 | Cellphire, Inc. | Compositions and methods for treatment of loss of fluids leading to hypotension and/or hypovolemia |
US20200224164A1 (en) | 2018-11-30 | 2020-07-16 | Cellphire, Inc. | Platelets as delivery agents |
EP3886879A4 (en) | 2018-11-30 | 2022-12-07 | Cellphire Inc. | PLATES AS DELIVERY AGENTS |
WO2020227149A1 (en) | 2019-05-03 | 2020-11-12 | Cellphire, Inc. | Materials and methods for producing blood products |
EP4013496A4 (en) | 2019-08-16 | 2023-10-18 | Cellphire Inc. | THROMBOSOMES AS AN ANTI-PLATELET DEACTIVATING AGENT |
WO2021158622A1 (en) | 2020-02-04 | 2021-08-12 | Cellphire, Inc. | Anti-fibrinolytic loaded platelets |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4775624A (en) | 1985-02-08 | 1988-10-04 | Eli Lilly And Company | Vectors and compounds for expression of human protein C |
US5516650A (en) | 1985-06-27 | 1996-05-14 | Zymogenetics, Inc. | Production of activated protein C |
US5550036A (en) | 1986-04-09 | 1996-08-27 | Eli Lilly And Company | Method for co-amplification of human protein C genes in human cells |
US4992373A (en) | 1987-12-04 | 1991-02-12 | Eli Lilly And Company | Vectors and compounds for direct expression of activated human protein C |
US4981952A (en) | 1988-10-04 | 1991-01-01 | Eli Lilly And Company | Method for the purification of vitamin K-dependent proteins |
IL97312A (en) | 1990-02-23 | 1999-01-26 | Lilly Co Eli | A method of generating a polypeptide in an eukaryotic vector AND recombinant surrogate cell containing an enhanced transcriptional control unit based on the primary late adenovirus coefficient |
US5506134A (en) * | 1990-10-22 | 1996-04-09 | Corvas International, Inc. | Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex |
AT402262B (de) | 1991-06-20 | 1997-03-25 | Immuno Ag | Arzneimittel enthaltend aktiviertes protein c |
MY110664A (en) | 1992-05-21 | 1999-01-30 | Lilly Co Eli | Protein c derivatives |
WO1997020043A1 (en) | 1995-11-30 | 1997-06-05 | Zymogenetics, Inc. | Protein c production in transgenic animals |
EA002149B1 (ru) * | 1997-04-28 | 2001-12-24 | Эли Лилли Энд Компани | Улучшенные способы приготовления активированного белка с |
DE69906568T2 (de) * | 1998-11-20 | 2004-02-12 | Eli Lilly And Co., Indianapolis | Behandlung von hämorrhagischem virusfieber mit protein c |
AU4188500A (en) * | 1999-04-30 | 2000-11-17 | Eli Lilly And Company | Protein c derivatives |
-
1999
- 1999-11-15 DE DE69906568T patent/DE69906568T2/de not_active Expired - Lifetime
- 1999-11-15 ES ES99965808T patent/ES2195655T3/es not_active Expired - Lifetime
- 1999-11-15 CN CN99813313A patent/CN1326356A/zh active Pending
- 1999-11-15 IL IL14222099A patent/IL142220A0/xx unknown
- 1999-11-15 AU AU21498/00A patent/AU2149800A/en not_active Abandoned
- 1999-11-15 WO PCT/US1999/027074 patent/WO2000030677A1/en active IP Right Grant
- 1999-11-15 BR BR9915460-9A patent/BR9915460A/pt not_active Application Discontinuation
- 1999-11-15 CA CA002351470A patent/CA2351470A1/en not_active Abandoned
- 1999-11-15 JP JP2000583560A patent/JP2002530353A/ja active Pending
- 1999-11-15 EP EP99965808A patent/EP1131091B1/en not_active Expired - Lifetime
- 1999-11-15 AT AT99965808T patent/ATE235915T1/de not_active IP Right Cessation
- 1999-11-19 US US09/444,479 patent/US6270764B1/en not_active Expired - Fee Related
-
2001
- 2001-04-25 US US09/842,337 patent/US6767539B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1131091A1 (en) | 2001-09-12 |
AU2149800A (en) | 2000-06-13 |
US20010028880A1 (en) | 2001-10-11 |
CN1326356A (zh) | 2001-12-12 |
WO2000030677A1 (en) | 2000-06-02 |
JP2002530353A (ja) | 2002-09-17 |
EP1131091B1 (en) | 2003-04-02 |
BR9915460A (pt) | 2001-07-17 |
DE69906568T2 (de) | 2004-02-12 |
ATE235915T1 (de) | 2003-04-15 |
DE69906568D1 (de) | 2003-05-08 |
CA2351470A1 (en) | 2000-06-02 |
US6270764B1 (en) | 2001-08-07 |
US6767539B2 (en) | 2004-07-27 |
ES2195655T3 (es) | 2003-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG103671A (en) | Combinations of sulphonylcarbamide-glytazone having synergetic effect for the treatment of diabetes | |
ATE234092T1 (de) | 2-alkylpyrrolidine | |
BG102999A (en) | New 2,3-diasubstituted-4-(3h)-quinazolinons | |
TR199900083T2 (xx) | Klaritromisinin kristal bi�imi I. | |
PT2329829E (pt) | Utilização de uridina em combinação com colina para o tratamento de disfunções neurológicas | |
BR9610838A (pt) | Processo para tratar um indivìduo tendo uma condição patológica envolvendo neovascularização. | |
IL142220A0 (en) | Method of treating viral hemorrhagic fever | |
BG100930A (en) | Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction | |
WO2000021513A3 (en) | Methods for treating multiple sclerosis | |
EP1632248B8 (en) | Anti-interleukin-9 antibody or anti-interleukin-9 receptor antibody for treating bronchial hyper-responsiveness | |
MX9605072A (es) | Dispositivo dispensador para pretratamiento. | |
EP0318233A3 (en) | Improvements in or relating to serotonin and norepinephrine uptake inhibitors | |
MX9604762A (es) | Nuevas sulfonamidas y procedimiento para su preparacion. | |
IL142255A0 (en) | Method of treating heparin-induced thrombocytopenia | |
HU9700024D0 (en) | Imidazopyridin-azolidinones | |
DK1100824T3 (da) | Forbindelser med væksthormonfrigivende egenskaber | |
DE3462688D1 (en) | 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases | |
IL142247A0 (en) | Method of treating sickle cell disease and thalassemia | |
IL142249A0 (en) | Method of treating thrombocytopenic purpura and hemolytic uremic syndrome | |
EP0116628A4 (en) | 1-ACYL-3-PYRIDYLMETHYLGUANIDINE AND THEIR USE AS AN ANI-HYPERTENSIVE. | |
EP1083914A4 (en) | TREATING ARTHRITIS AND OTHER SIMILAR DISORDERS | |
ZA893310B (en) | Novel strobilurine derivatives,their preparation and their use | |
IL138117A0 (en) | 5-imino-13-deoxy anthracycline derivatives, their uses and processes for preparing them | |
UA15363A (uk) | Засіб для лікуваhhя відкритих пошкоджеhь |